Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Surya Murty, Samuel T. Haile, Corinne Beinat, Amin Aalipour, Israt S. Alam, Tara Murty, Travis M. Shaffer, Chirag B. Patel, Edward E. Graves, Crystal L. Mackall & Sanjiv S. Gambhir. (2020) Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma model. OncoImmunology 9:1.
Read now
Read now
Candice D. Carpenter, Iyad Alnahhas, Javier Gonzalez, Pierre Giglio & Vinay K. Puduvalli. (2019) Changing paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target. Expert Review of Neurotherapeutics 19:7, pages 663-677.
Read now
Read now
Articles from other publishers (30)
Zaoqu Liu, Meixin Shi, Yuqing Ren, Hui Xu, Siyuan Weng, Wenjing Ning, Xiaoyong Ge, Long Liu, Chunguang Guo, Mengjie Duo, Lifeng Li, Jing Li & Xinwei Han. (2023) Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy. Molecular Cancer 22:1.
Crossref
Crossref
Stefaan W. Van Gool, Jennifer Makalowski, Peter Van de Vliet, Stefanie Van Gool, Tobias Sprenger, Volker Schirrmacher & Wilfried Stuecker. (2023) Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience. Cancers 15:4, pages 1194.
Crossref
Crossref
Zi-Hua Guo, Saadullah Khattak, Mohd Ahmar Rauf, Mohammad Azam Ansari, Mohammad N. Alomary, Sufyan Razak, Chang-Yong Yang, Dong-Dong Wu & Xin-Ying Ji. (2023) Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders. Molecules 28:3, pages 1283.
Crossref
Crossref
Wan-Soo Yoon & Dong-Sup Chung. (2023) Advanced T and NK Cell Therapy for Glioblastoma. Journal of Korean Neurosurgical Society.
Crossref
Crossref
Yifan Xu, Chao Wang, Shifang Li, Han Zhou & Yugong Feng. (2022) Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma. Frontiers in Genetics 13.
Crossref
Crossref
Jia-Jia Li, Xuan-Ping Xia, Li-Min Wu, Zheng Zhu, Yu-Ning Shi, Xu-Chao Zhang, Yu-Shan Xia & Guang-Rong Lu. (2022) Cancer suppression by ferroptosis and its role in digestive system tumors. World Chinese Journal of Digestology 30:16, pages 718-728.
Crossref
Crossref
Landon J. Hansen, Rui Yang, Kristen Roso, Wenzhe Wang, Lee Chen, Qing Yang, Christopher J. Pirozzi & Yiping He. (2022) MTAP loss correlates with an immunosuppressive profile in GBM and its substrate MTA stimulates alternative macrophage polarization. Scientific Reports 12:1.
Crossref
Crossref
Lan B. Hoang-Minh & Duane A. Mitchell. 2022. Immunotherapeutic Strategies for the Treatment of Glioma. Immunotherapeutic Strategies for the Treatment of Glioma
73
89
.
Vignesh Kamath. (2021) Cancer vaccines: An unkept promise?. Drug Discovery Today 26:6, pages 1347-1352.
Crossref
Crossref
Conall Hayes. (2020) Cellular immunotherapies for cancer. Irish Journal of Medical Science (1971 -) 190:1, pages 41-57.
Crossref
Crossref
Takahide Nejo, Abigail Mende & Hideho Okada. (2020) The current state of immunotherapy for primary and secondary brain tumors: similarities and differences. Japanese Journal of Clinical Oncology 50:11, pages 1231-1245.
Crossref
Crossref
Sumaira Hanif, Pir Muhammad, Rose Chesworth, Fawad Ur Rehman, Rong-jun Qian, Meng Zheng & Bing-yang Shi. (2020) Nanomedicine-based immunotherapy for central nervous system disorders. Acta Pharmacologica Sinica 41:7, pages 936-953.
Crossref
Crossref
Armita M. Gorabi, Saeideh Hajighasemi, Thozhukat Sathyapalan & Amirhossein Sahebkar. (2019) Cell transfer‐based immunotherapies in cancer: A review. IUBMB Life 72:4, pages 790-800.
Crossref
Crossref
Jingyu Wang, Fang Shen, Ying Yao, Lin-lin Wang, Yongjian Zhu & Jue Hu. (2020) Adoptive Cell Therapy: A Novel and Potential Immunotherapy for Glioblastoma. Frontiers in Oncology 10.
Crossref
Crossref
Zhengting He. Main issues and current strategies in enhancing the efficacy of chimeric antigen receptor T-cell therapy among tumor treatments. Main issues and current strategies in enhancing the efficacy of chimeric antigen receptor T-cell therapy among tumor treatments.
Dimitrios Strepkos, Mariam Markouli, Alexia Klonou, Christina Piperi & Athanasios G. Papavassiliou. (2019) Insights in the immunobiology of glioblastoma. Journal of Molecular Medicine 98:1, pages 1-10.
Crossref
Crossref
Lanlan Yang, Artsiom Antanovich, Anatol Prudnikau, Olga S Taniya, Kirill V Grzhegorzhevskii, Pavel Zelenovskiy, Tatiana Terpinskaya, Jianguo Tang & Mikhail Artemyev. (2019) Highly luminescent Zn–Cu–In–S/ZnS core/gradient shell quantum dots prepared from indium sulfide by cation exchange for cell labeling and polymer composites. Nanotechnology 30:39, pages 395603.
Crossref
Crossref
Alessandra Raimondi, Giovanni Randon, Pierangela Sepe, Melanie Claps, Elena Verzoni, Filippo de Braud & Giuseppe Procopio. (2019) The Evaluation of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: Open Challenges in the Clinical Practice. International Journal of Molecular Sciences 20:17, pages 4263.
Crossref
Crossref
Ju. P. Rubtsova, D. Ya. Aleynik, O. P. Zhivtsov & V. N. Mitrofanov. (2019) In vitro dendritic cell maturation isolated from healthy people and patients with Staphylococcus aureuscaused chronic osteomyelitis. Russian Journal of Infection and Immunity 9:1, pages 87-94.
Crossref
Crossref
Vishal Jindal. (2018) Role of Chimeric Antigen Receptor T Cell Therapy in Glioblastoma Multiforme. Molecular Neurobiology 55:11, pages 8236-8242.
Crossref
Crossref
Xiaoming Hu, Rehana K. Leak, Angus W. Thomson, Fang Yu, Yuguo Xia, Lawrence R. Wechsler & Jun Chen. (2018) Promises and limitations of immune cell-based therapies in neurological disorders. Nature Reviews Neurology 14:9, pages 559-568.
Crossref
Crossref
Sarah Lapointe, Arie Perry & Nicholas A Butowski. (2018) Primary brain tumours in adults. The Lancet 392:10145, pages 432-446.
Crossref
Crossref
Xinglong Qu, Ying Tang & Shucheng Hua. (2018) Immunological Approaches Towards Cancer and Inflammation: A Cross Talk. Frontiers in Immunology 9.
Crossref
Crossref
Julius W. Kim, Katarzyna C. Pituch, Annie Xiao, Jacob S. Young, Wojciech K. Panek, Megan E. Muroski, Aida Rashidi, J. Robert Kane, Deepak Kanojia & Maciej S. Lesniak. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
211
227
.
Hua Zhang, Yue Wu, Jing Wang, Zhongmin Tang, Yan Ren, Dalong Ni, Hongbo Gao, Ruixue Song, Teng Jin, Qiao Li, Wenbo Bu & Zhenwei Yao. (2018)
In Vivo MR Imaging of Glioma Recruitment of Adoptive T-Cells Labeled with NaGdF
4
-TAT Nanoprobes
. Small 14:3, pages 1702951.
Crossref
Crossref
John K. Wiencke, Devin C. Koestler, Lucas A. Salas, Joseph L. Wiemels, Ritu P. Roy, Helen M. Hansen, Terri Rice, Lucie S. McCoy, Paige M. Bracci, Annette M. Molinaro, Karl T. Kelsey, Margaret R. Wrensch & Brock C. Christensen. (2017) Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival. Clinical Epigenetics 9:1.
Crossref
Crossref
John H. SampsonMarcela V. MausCarl H. June. (2017) Immunotherapy for Brain Tumors. Journal of Clinical Oncology 35:21, pages 2450-2456.
Crossref
Crossref
Gary Kohanbash, Diego A. Carrera, Shruti Shrivastav, Brian J. Ahn, Naznin Jahan, Tali Mazor, Zinal S. Chheda, Kira M. Downey, Payal B. Watchmaker, Casey Beppler, Rolf Warta, Nduka A. Amankulor, Christel Herold-Mende, Joseph F. Costello & Hideho Okada. (2017) Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas. Journal of Clinical Investigation 127:4, pages 1425-1437.
Crossref
Crossref
Frank Lieberman. (2017) Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials. F1000Research 6, pages 1892.
Crossref
Crossref
Smitha Menon, Sarah Shin & Grace Dy. (2016) Advances in Cancer Immunotherapy in Solid Tumors. Cancers 8:12, pages 106.
Crossref
Crossref